Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 64

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 64
---
 drafts of the quarterly and annual reports.

Based on the reviews, discussions, and written disclosures referred to above, the Audit Committee recommended to the Board that the Company’s audited financial statements be included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 for filing with the SEC.

Craig Johnson, Chairperson

Michael Kaseta

Christian Waage

45

FEES OF THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM The following table shows the aggregate fees for services rendered in or provided for 2024 and 2023, as applicable, by Withum, our independent registered public accounting firm.

|                        |     |   |    2024 |     |   |    2023 |     |    |
|:-----------------------|:----|:--|--------:|:----|:--|--------:|:----|---:|
| Audit Fees (1)         |     | $ | 624,795 |     | $ | 604,880 |     | -4 |
| Audit-related Fees (2) |     |   |       — |     | $ |  24,960 |     |    |
| Tax Fees (3)           |     |   |       — |     | $ | 102,903 |     |    |
| All Other Fees         |     |   |       — |     |   |       — |     |    |
| Total                  |     | $ | 624,795 |     | $ | 732,743 |     |    |

(1) The audit fees for both 2024 and 2023 were for professional services rendered in connection with the audit of our annual financial statements and internal control over financial reporting and for the review of the quarterly financial statements. The amounts also include fees for services that are normally provided by the auditor in connection with regulatory filings and engagements for the years identified. (2) The audit-related fees for 2023 include fees for procedures performed during that year in connection with the audit of the Heron Therapeutics, Inc. 401(k) Plan. (3) Tax fees for 2023 consist of fees for tax compliance. (4) The amount of the audit fees for 2023 has been updated to reflect additional payments made in 2024 related to the 2023 audit which was paid after the proxy statement for the 2024 Annual Meeting of Stockholders was filed on April 29, 2024.